PERSONALIS

personalis-logo

Personalis combines both the technology of sequencing and interpretation, with an extensive history of peer-reviewed publication and commercial success. It is providing an extensive molecular view of a patient’s tumor and characterizes its interplay with the immune system. It aids in the development of safer, effective precision cancer therapies, immunotherapies, and personalized medicines.

#SimilarOrganizations #People #Financial #Event #Website #More

PERSONALIS

Industry:
Biotechnology Genetics Health Care Health Diagnostics

Founded:
2011-08-01

Address:
Menlo Park, California, United States

Country:
United States

Website Url:
http://www.personalis.com

Total Employee:
251+

Status:
Active

Contact:
+1 650 752 1301

Total Funding:
225.1 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress


Similar Organizations

bluebird-bio-logo

Bluebird Bio

Bluebird Bio offers products based on the transformative potential of gene therapy for patients with genetic and orphan diseases.

cofactor-genomics-logo

Cofactor Genomics

Cofactor Genomics builds multidimensional models of disease to deliver true precision medicine.

editas-medicine-logo

Editas Medicine

Editas Medicine is engaged in discovering and developing a novel class of genome editing therapeutics.

fulcrum-therapeutics-logo

Fulcrum Therapeutics

Fulcrum Therapeutics is a biotechnology company that develops new medicines to treat patients with rare genetic diseases.

homology-medicines-logo

Homology Medicines

Homology Medicines is a genetic medicines company dedicated to transforming the lives of patients suffering from rare genetic diseases.

human-longevity-logo

Human Longevity

Human Longevity is a genomic-based, health intelligence company empowering proactive healthcare and enabling a life better lived.

moderna-therapeutics-logo

Moderna Therapeutics

Moderna Therapeutics is a biotechnology company that specializes in drug discovery and drug development based on messenger RNA.

neogenomics-logo

NeoGenomics

NeoGenomics is a cancer reference laboratory that provides cancer testing and partnership programs to pathologists and oncologists.

caredx-logo

CareDx

CareDx is a novel mol­e­c­u­lar diagnos­tics com­pany.


Current Advisors List

woodrow-myers_image

Woodrow Myers Member Board Of Directors @ Personalis
Board_member
2021-03-01

Current Employees Featured

john-west_image

John West
John West Chief Executive Officer @ Personalis
Chief Executive Officer
2011-08-01

aaron-tachibana_image

Aaron Tachibana
Aaron Tachibana Chief Financial Officer @ Personalis
Chief Financial Officer
2019-03-01

clinton-musil_image

Clinton Musil
Clinton Musil Chief Business Officer @ Personalis
Chief Business Officer

carol-j-tillis_image

Carol J. Tillis
Carol J. Tillis Vice President, Finance & Administration @ Personalis
Vice President, Finance & Administration
2011-01-01

christian-haudenschild_image

Christian Haudenschild
Christian Haudenschild Senior Vice President @ Personalis
Senior Vice President
2021-08-01

dawn-mchugh_image

Dawn McHugh
Dawn McHugh Senior Director, Strategic Business Development @ Personalis
Senior Director, Strategic Business Development
2020-04-01

laurie-goodman_image

Laurie Goodman
Laurie Goodman Senior Director, Scientific & Medical Affairs @ Personalis
Senior Director, Scientific & Medical Affairs
2021-04-01

stanley-welle_image

Stanley Welle
Stanley Welle Director, Strategic Business Development @ Personalis
Director, Strategic Business Development
2020-01-01

not_available_image

James Azzaro
James Azzaro Vice President of Diagnostic Sales @ Personalis
Vice President of Diagnostic Sales
2022-04-01

richard-chen_image

Richard Chen
Richard Chen Chief Medical Officer and SVP of R&D @ Personalis
Chief Medical Officer and SVP of R&D

Founder


atul-butte_image

Atul Butte

Stock Details


Company's stock symbol is NASDAQ:PSNL

Investors List

abingworth-management_image

Abingworth

Abingworth investment in Series C - Personalis

stanford-university_image

Stanford University

Stanford University investment in Series C - Personalis

lightspeed-venture-partners_image

Lightspeed Venture Partners

Lightspeed Venture Partners investment in Series C - Personalis

mohr-davidow-ventures_image

Mohr Davidow Ventures

Mohr Davidow Ventures investment in Series C - Personalis

abingworth-management_image

Abingworth

Abingworth investment in Series B - Personalis

lightspeed-venture-partners_image

Lightspeed Venture Partners

Lightspeed Venture Partners investment in Series B - Personalis

mohr-davidow-ventures_image

Mohr Davidow Ventures

Mohr Davidow Ventures investment in Series B - Personalis

lightspeed-venture-partners_image

Lightspeed Venture Partners

Lightspeed Venture Partners investment in Series A - Personalis

abingworth-management_image

Abingworth

Abingworth investment in Series A - Personalis

stanford-university_image

Stanford University

Stanford University investment in Series A - Personalis

Newest Events participated

ici-boston-2017_event_image Participated in ICI Boston 2017 on 2017-03-14 as exhibitor

Official Site Inspections

http://www.personalis.com Semrush global rank: 4.17 M Semrush visits lastest month: 2.85 K

  • Host name: 172.67.73.134
  • IP address: 172.67.73.134
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Personalis"

Personalis | Personalizing Precision Oncology | Since 2011

We're building a world where personalized testing delivers greater confidence and exceptional outcomes for cancer patients via precision oncology.See details»

Personalis - Crunchbase Company Profile & Funding

Personalis is a contract research organization and genome-scale diagnostics services company specializing in genome guided medicine. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. ... Personalis …See details»

Personalis | Meet the Team | Active cancer management

Meet the people building the next standard of cancer care. Everyone has the power to impact our pursuit of personalized, active cancer management.See details»

Investor Relations | Personalis

Personalis, Inc. is a growing cancer genomics company transforming the development of next-generation therapies by providing more comprehensive molecular data about each patient’s …See details»

Personalis, Inc. - AnnualReports.com

Personalis, Inc. is a leader in population sequencing and cancer genomics, with a focus on data, scale, efficiency and quality. Personalis operates one of the largest sequencing operations globally and is currently the sole sequencing provider …See details»

Personalis Advances Business Strategy with Investment from …

Dec 18, 2024 FREMONT, Calif.--(BUSINESS WIRE)--Dec. 19, 2024-- Personalis, Inc. (NASDAQ: PSNL) announced today agreements with long time collaborators Merck and …See details»

Personalis: Contact Details, Revenue, Funding, Employees and …

Personalis offers breakthrough personalized cancer testing with its NeXT Personal tumor-informed liquid biopsy, providing highly sensitive MRD detection using minimal cfDNA and …See details»

Personalis - Funding, Financials, Valuation & Investors - Crunchbase

Personalis is a contract research organization and genome-scale diagnostics services company specializing in genome guided medicine. Search Crunchbase. Start Free Trial . Chrome …See details»

Personalis Company Profile - Office Locations, Competitors, …

Oct 29, 2024 Personalis has 5 employees across 2 locations and $73.48 m in annual revenue in FY 2023. See insights on Personalis including office locations, competitors, revenue, …See details»

Personalis - Contacts, Employees, Board Members, Advisors

Personalis is a contract research organization and genome-scale diagnostics services company specializing in genome guided medicine. Search Crunchbase. Start Free Trial . Chrome …See details»

Personalis Expands Leadership Team with Appointment of Susan …

Feb 8, 2021 “Susan Moriconi brings over 20 years of experience in human resources and organization strategy, including deep experience in the life sciences industry. She is the right …See details»

Personalis - Overview, News & Similar companies | ZoomInfo.com

Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) FREMONT, Calif.--(BUSINESS WIRE)--Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics …See details»

Personalis Reports Preliminary Fourth Quarter and Full Year 2024 …

2 days ago FREMONT, Calif., January 07, 2025--Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today reported unaudited preliminary revenue for …See details»

Promising Outlook for Personalis: Buy Rating Supported by Strong ...

2 days ago Personalis reports preliminary Q4 revenue $16.8M, consensus $15.5M Personalis raises FY24 revenue view to $84.6M from $83M-$84M Personalis up 3% at $6.15 after Q4 pre …See details»

Personalis | Specificity Study

Organization * Job Title. Phone number. We’re committed to your privacy. Personalis uses the information you provide to us to contact you about our relevant content, products, and …See details»

Investor Relations | Personalis

Nov 6, 2024 The Personalis Clinical Laboratory is GxP aligned as well as CLIA’88-certified and CAP-accredited. Stock Information. Change Volume 52 Week High 52 Week Low Jan 8, 2025 …See details»

Clinical Portal - Personalis

Personalis Clinical Portal. Clinical Portal. Downtime for Maintenance. Scheduled downtime on January 06, 2025 @1.00 PM PST to 5.00 PM PST. Thanks for your patience. Please Login …See details»

Personalis Further Expands Leadership Team With Appointment of …

Jul 16, 2020 MENLO PARK, Calif.--(BUSINESS WIRE)--Jul. 16, 2020--Personalis, Inc., (Nasdaq: PSNL) a leader in advanced genomics for cancer, today announced the appointment …See details»

What is Personalis? Company Culture, Mission, Values

How do job seekers rate their interview experience at Personalis? 46% of job seekers rate their interview experience at Personalis as positive. Candidates give an average difficulty score of …See details»

Personalis | Tissue and Liquid Biopsy Assay for Solid Tumor

By combining our MRD liquid biopsy assay and immunogenomics platforms, you analyze the same tissue sample with no additional tumor material required.See details»

linkstock.net © 2022. All rights reserved